A Brief Review on Medication in the Statin Family that Lowers Cholesterol-Atorvastatin (Lipitor)
Received Date: Nov 22, 2022 / Accepted Date: Dec 19, 2022 / Published Date: Dec 20, 2022
Abstract
An HMG-CoA reductase inhibitor called atorvastatin is used to lower cholesterol levels and lessen the risk of cardiovascular disease, including as myocardial infarction and stroke. The objective of this paper is to provide a brief note on the pharmacokinetics of lipid-lowering medicine belonging to the statin class of drugs is Atorvastatin.
Citation: Stevens J (2022) A Brief Review on Medication in the Statin Family thatLowers Cholesterol -Atorvastatin (Lipitor). J Pharmacokinet Exp Ther 6: 159. Doi: 10.4172/jpet.1000159
Copyright: © 2022 Stevens J. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Open Access Journals
Article Tools
Article Usage
- Total views: 920
- [From(publication date): 0-2022 - Nov 07, 2024]
- Breakdown by view type
- HTML page views: 728
- PDF downloads: 192
